129 related articles for article (PubMed ID: 3244388)
1. Species variations in 5-HT3 recognition sites labeled by 3H-quipazine in the central nervous system.
Peroutka SJ
Naunyn Schmiedebergs Arch Pharmacol; 1988 Nov; 338(5):472-5. PubMed ID: 3244388
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
[TBL] [Abstract][Full Text] [Related]
3. Autoradiography of [3H]quipazine in rodent brain.
Perry DC
Eur J Pharmacol; 1990 Oct; 187(1):75-85. PubMed ID: 2272355
[TBL] [Abstract][Full Text] [Related]
4. Characterization of [3H]quipazine binding to 5-hydroxytryptamine3 receptors in rat brain membranes.
Milburn CM; Peroutka SJ
J Neurochem; 1989 Jun; 52(6):1787-92. PubMed ID: 2566650
[TBL] [Abstract][Full Text] [Related]
5. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM
Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546
[TBL] [Abstract][Full Text] [Related]
6. Labelling of 5-hydroxytryptamine3 receptors with a novel 5-HT3 receptor ligand, [3H]RS-42358-197.
Wong EH; Bonhaus DW; Wu I; Stefanich E; Eglen RM
J Neurochem; 1993 Mar; 60(3):921-30. PubMed ID: 8436978
[TBL] [Abstract][Full Text] [Related]
7. Improvement of 5-HT3 receptor binding assay: enhancement of specific [3H]quipazine binding with Triton X-100-treated membranes from rat cortex.
Une T; Furukawa K; Komiya M
Jpn J Pharmacol; 1991 Oct; 57(2):197-203. PubMed ID: 1812298
[TBL] [Abstract][Full Text] [Related]
8. Different densities of 5-HT3 receptors are labeled by [3H]quipazine, [3H]GR 65630 and [3H]granisetron.
Wong EH; Bonhaus DW; Lee JA; Wu I; Loury DN; Eglen RM
Neuropharmacology; 1993 Sep; 32(9):869-75. PubMed ID: 8232790
[TBL] [Abstract][Full Text] [Related]
9. Agonist interactions with 5-HT3 receptor recognition sites in the rat entorhinal cortex labelled by structurally diverse radioligands.
Barnes JM; Barnes NM; Costall B; Jagger SM; Naylor RJ; Robertson DW; Roe SY
Br J Pharmacol; 1992 Feb; 105(2):500-4. PubMed ID: 1559139
[TBL] [Abstract][Full Text] [Related]
10. [3H]quipazine labels 5-HT3 recognition sites in rat cortical membranes.
Peroutka SJ; Hamik A
Eur J Pharmacol; 1988 Mar; 148(2):297-9. PubMed ID: 3378579
[No Abstract] [Full Text] [Related]
11. SR 57227A: a potent and selective agonist at central and peripheral 5-HT3 receptors in vitro and in vivo.
Bachy A; Héaulme M; Giudice A; Michaud JC; Lefevre IA; Souilhac J; Manara L; Emerit MB; Gozlan H; Hamon M
Eur J Pharmacol; 1993 Jun; 237(2-3):299-309. PubMed ID: 7689975
[TBL] [Abstract][Full Text] [Related]
12. [3H]ICS 205-930 labels 5-HT3 recognition sites in membranes of cat and rabbit vagus nerve and superior cervical ganglion.
Hoyer D; Waeber C; Karpf A; Neijt H; Palacios JM
Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):396-402. PubMed ID: 2586633
[TBL] [Abstract][Full Text] [Related]
13. Species variations in RU 24969 interactions with non-5-HT1A binding sites.
Heuring RE; Schlegel JR; Peroutka SJ
Eur J Pharmacol; 1986 Mar; 122(2):279-82. PubMed ID: 2940097
[TBL] [Abstract][Full Text] [Related]
14. Membrane-bound and solubilized brain 5HT3 receptors: improved radioligand binding assays using bovine area postrema or rat cortex and the radioligands 3H-GR65630, 3H-BRL43694, and 3H-LY278584.
Miller K; Weisberg E; Fletcher PW; Teitler M
Synapse; 1992 May; 11(1):58-66. PubMed ID: 1318585
[TBL] [Abstract][Full Text] [Related]
15. Evidence that the atypical 5-HT3 receptor ligand, [3H]-BRL46470, labels additional 5-HT3 binding sites compared to [3H]-granisetron.
Steward LJ; Ge J; Bentley KR; Barber PC; Hope AG; Lambert JJ; Peters JA; Blackburn TP; Barnes NM
Br J Pharmacol; 1995 Sep; 116(2):1781-8. PubMed ID: 8528560
[TBL] [Abstract][Full Text] [Related]
16. Identification of 5-HT3 binding sites in rat spinal cord synaptosomal membranes.
Glaum SR; Anderson EG
Eur J Pharmacol; 1988 Nov; 156(2):287-90. PubMed ID: 3240771
[TBL] [Abstract][Full Text] [Related]
17. '[3H]quipazine' degradation products label 5-HT uptake sites.
Schmidt AW; Hurt SD; Peroutka SJ
Eur J Pharmacol; 1989 Nov; 171(1):141-3. PubMed ID: 2533080
[No Abstract] [Full Text] [Related]
18. The interaction of trichloroethanol with murine recombinant 5-HT3 receptors.
Downie DL; Hope AG; Belelli D; Lambert JJ; Peters JA; Bentley KR; Steward LJ; Chen CY; Barnes NM
Br J Pharmacol; 1995 Apr; 114(8):1641-51. PubMed ID: 7541281
[TBL] [Abstract][Full Text] [Related]
19. Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system.
Hussain JF; Kendall DA; Wilson VG
Br J Pharmacol; 1993 Jul; 109(3):831-7. PubMed ID: 8102937
[TBL] [Abstract][Full Text] [Related]
20. Common pharmacological and physico-chemical properties of 5-HT3 binding sites in the rat cerebral cortex and NG 108-15 clonal cells.
Bolaños FJ; Schechter LE; Miquel MC; Emerit MB; Rumigny JF; Hamon M; Gozlan H
Biochem Pharmacol; 1990 Oct; 40(7):1541-50. PubMed ID: 2222509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
